Sun Pharma Advanced Research Company Q3 FY24 loss at Rs. 99.65 Cr
Sun Pharma Advanced Research Company has reported total income of Rs. 20.25 crores during the period ended December 31, 2023
Sun Pharma Advanced Research Company has reported total income of Rs. 20.25 crores during the period ended December 31, 2023
The company intends to respond to the two minor observations within the stipulated time
The new campus has been designed as an employee-centred experience and ecosystem zone
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
The receipt of this permission paves way for the launch of Andexanet alfa powder for solution for infusion 200 mg (Andexxa) in India
This product has sales of about US$ 20 million in Europe
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
The latest upgraded Tele Clinic is Artificial Intelligence (AI) - driven to provide healthcare facilities in far flung areas of the region, where such facilities are either not available or inadequately available
Subscribe To Our Newsletter & Stay Updated